(Press-News.org) SAN FRANCISCO— Estrogen replacement therapy is associated with a significant decrease in anxiety symptoms among girls with anorexia nervosa, a new clinical trial finds. The results will be presented today at The Endocrine Society's Annual Meeting in San Francisco.
"This is the first study to show that estrogen replacement ameliorates the tendency for anxiety in anorexia nervosa and may prevent increasing body dissatisfaction with weight gain," said the study's lead author Madhusmita Misra, MD, MPH, pediatric endocrinologist and associate professor of pediatrics at the Massachusetts General Hospital and Harvard Medical School in Boston, MA. "This is very important given that anorexia nervosa can be difficult to treat, and underlying anxiety, eating attitudes and concerns of body shape with increasing weight during treatment may reduce the success of treatment programs."
Anorexia nervosa is a severe eating disorder that primarily affects teenage girls, although boys, as well as older and younger people, can also develop it. Approximately 0.2-1 percent of teenage girls suffer from the disorder.
The disorder is characterized by a distorted body image, which causes patients to view themselves as heavy, or fat, even when their body-mass index is well below the normal range. As the disease progresses, patients become increasingly preoccupied with weight loss through restricting food and/or increasing activity with intense, frequent exercising. Some resort to purging behaviors to rid themselves of any food that they consume.
Complications include depression, increased risk of suicide and weakened bones, which increase the risk of fractures and osteoporosis. Among girls, menstrual periods stop occurring as body weight and estrogen production drop. If left untreated, the disorder can cause death. Unfortunately, anorexia can be quite difficult to treat, and relapse is common.
In this study, investigators found that anxiety scores on a standardized questionnaire decreased as estrogen levels increased. This relationship was unaffected by weight gain. Additionally, if weight gain did occur, estrogen replacement appeared to prevent a worsening of attitudes toward body image and food, as assessed using the Eating Disorders Inventory-II questionnaire.
"Identification of therapies that reduce the tendency to experience anxiety and reduce body dissatisfaction with weight gain may have a major impact in reducing relapse," Misra said. "These findings have the potential to impact therapy in anorexia nervosa with early implementation of estrogen replacement in girls who are estrogen deficient."
Participants included 72 teenage girls diagnosed with anorexia nervosa. At the start of the study, all were between 13 and 18 years old, and had a measured bone age of at least 15years.
Investigators randomly assigned participants to receive estrogen or placebo for 18 months. Of the 72 initial participants, 38 received estrogen and 34 received placebo. At the study's start and end, participants completed questionnaires designed to assess anxiety, and attitudes toward eating and body image. Thirty-seven participants completed the study, with 20 receiving estrogen and 17 receiving placebo.
###
The National Institutes of Health's National Institute of Diabetes, Digestive and Kidney Disorders funded the study.
Founded in 1916, The Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 16,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.
Estrogen replacement therapy helps reduce anxiety in anorexia nervosa
2013-06-17
ELSE PRESS RELEASES FROM THIS DATE:
Vitamin D deficiency may raise allergy and asthma risk in obese children, teens
2013-06-17
One reason why obese children and teenagers are more likely to have hard-to-control asthma and allergies may be vitamin D deficiency, a new study finds. Results of the study will be presented Tuesday at The Endocrine Society's 95th Annual Meeting in San Francisco.
"The increased risk for asthma and allergies, and for more severe cases of allergic disease, in overweight and obese adolescents has not previously been understood," said Candace Percival, MD, lead investigator and a pediatric endocrinology fellow at Walter Reed National Military Medical Center, Bethesda, MD. ...
Bushfires in north of Western Australia
2013-06-17
According to the Australian Government Bureau of Meterology, "In the warm, dry and sunny winter and spring, when grasses are dead and fuels have dried, northern Australia becomes most susceptible to bushfires. Intense high-pressure systems over South Australia producing strong southeast to northeast winds increase the risk of bushfires."
Since Australia is heading into their winter as the northern climates head into summer, the north of Western Australia is ripe for bushfires. Many have already begun as evidenced from this satellite pass by NASA's Aqua satellite which ...
Adolescents' high-fat diet impairs memory and learning
2013-06-17
SAN FRANCISCO-- A high-fat diet in adolescence appears to have long-lasting effects on learning and memory during adulthood, a new study in mice finds. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Adolescent mice fed a normal-calorie but high-fat diet became moderately obese but not diabetic, and they displayed significantly impaired spatial memory, according to the study authors, from CEU-San Pablo University (Universidad CEU-San Pablo) in Madrid. Spatial memory allows recording of information needed to navigate ...
Impaired heart function among obese children may help predict later disease
2013-06-17
SAN FRANCISCO-- Impaired heart function among obese children and adolescents may be an indicator of future heart disease, a new clinical trial finds. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Obesity rates in developed countries worldwide are climbing among all age groups, including children. In the United States today, one-third of children are overweight or obese, which raises concerns about the effects of early weight gain on future health.
Previous research showed that obesity in childhood can cause a type ...
Weight loss drug added to diet and exercise improves blood sugar control
2013-06-17
SAN FRANCISCO-- The new weight loss drug lorcaserin (Belviq) appears to improve blood sugar control in nondiabetic, overweight individuals, independent of the amount of weight they lose, a new study finds. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Lorcaserin activates a serotonin receptor (5HT2C) in the brain believed to decrease appetite and promote a sense of fullness, thus encouraging decreased food consumption, said the study's principal investigator, Louis Aronne, MD, professor of clinical medicine at ...
Source of tumor growth in aggressive prostate cancer found
2013-06-17
SAN FRANCISCO-Researchers have discovered a molecular switch that explains, at least in part, how some fast-growing prostate cancers become resistant to hormone treatment, a new study conducted in human cell cultures and mice finds. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
A factor not normally found in the prostate, called Steroidogenic Factor 1, stimulates production of new steroid hormones and increases cell multiplication to fuel growth of the tumor, researchers from the University of Wisconsin-Madison, found.
"This ...
Excessive salt consumption appears to be bad for your bones
2013-06-17
SAN FRANCISCO-- A high-salt diet raises a woman's risk of breaking a bone after menopause, no matter what her bone density is, according to a new study that will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
The Japanese study found that older women who consumed the highest amount of sodium had more than four times the risk of a nonvertebral fracture, or fracture at any site other than the spine. That finding held true even after the researchers made adjustments for many other characteristics that could affect fracture risk, said ...
Whole body vibration therapy increases bone strength
2013-06-17
SAN FRANCISCO-- A treatment known as whole body vibration therapy significantly increases bone strength among adolescents with cerebral palsy, a new clinical trial from New Zealand shows. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Cerebral palsy affects more than half a million people in the United States. Caused by brain damage around the time of birth, the disorder affects muscle tone and movement, which can severely decrease the quality of life by making walking and other daily activities difficult. As movement ...
Osteoporosis drug may help treat advanced hormone-sensitive breast cancer
2013-06-17
A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study in mice shows. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
The medication, bazedoxifene, which is approved in Europe under the brand name Conbriza for the treatment and prevention of postmenopausal osteoporosis, also reduced estrogen activity and estrogen receptor levels in cultured human breast cancer cells, the study authors reported.
"Bazedoxifene, a known, safe drug approved ...
'Gene signature' test diagnoses benign thyroid growths
2013-06-17
A new genetic test accurately and consistently diagnoses benign growths, or nodules, on the thyroid gland, according to a study from Chile. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
"We have developed a 'gene signature' that effectively identifies benign thyroid nodules," said Hernan Gonzalez, MD, PhD, associate professor at the Pontifical Catholic University of Chile in Santiago. "This test is potentially useful to identify patients who do not require surgery."
The thyroid gland, located in the front of ...